David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Herc Holdings
HRI
$5.41B
| $32.7M | 0.06% |
1,034,226
-510,643
| -33% | -$15M |
|
377
Cimpress
CMPR
$2.13B
| $32.6M | 0.06% |
359,999
-73,607
| -17% | -$6.04M |
|
378
Emergent Biosolutions
EBS
$260M
| $32.4M | 0.06% |
891,876
+31,180
| +4% | +$1.1M |
|
379
PNC Financial Services
PNC
$97B
| $32.3M | 0.06% |
381,983
+101,708
| +36% | +$8.66M |
|
380
Camden Property Trust
CPT
$10.8B
| $32.1M | 0.06% |
382,326
+16,784
| +5% | +$1.28M |
|
|
SPLS
381
DELISTED
Staples Inc
SPLS
| $32.1M | 0.06% |
2,912,955
+324,830
| +13% | +$3.05M |
|
|
WNR
382
DELISTED
Western Refining Inc
WNR
| $32M | 0.06% |
1,101,520
-1,918,399
| -64% | -$57.9M |
|
383
CALL
Cisco
CSCO
$438B
| $31.9M | 0.06% |
1,120,800
+321,200
| +40% | +$8.26M |
|
384
Arch Capital
ACGL
$33.9B
| $31.8M | 0.06% |
1,341,243
+242,784
| +22% | +$5.53M |
|
385
PUT
McDonald's
MCD
$192B
| $31.7M | 0.06% |
252,400
-457,800
| -64% | -$54.7M |
|
|
WBA
386
DELISTED
Walgreens Boots Alliance
WBA
| $31.7M | 0.06% |
376,346
-872,642
| -70% | -$69.7M |
|
|
CHK
387
DELISTED
Chesapeake Energy Corporation
CHK
| $31.5M | 0.06% |
38,267
+37,809
| +8,255% | +$26.8M |
|
388
Duke Energy
DUK
$93.4B
| $31.5M | 0.06% |
390,268
+370,265
| +1,851% | +$28M |
|
389
CALL
Coca-Cola
KO
$392B
| $31.4M | 0.06% |
677,000
+63,200
| +10% | +$2.75M |
|
|
SDRL
390
DELISTED
Seadrill Limited Common Stock
SDRL
| $31.3M | 0.06% |
35,389
+35,147
| +14,524% | +$25.3M |
|
|
MDRX
391
DELISTED
Veradigm Inc. Common Stock
MDRX
| $31.2M | 0.06% |
2,363,724
-134,630
| -5% | -$1.77M |
|
|
HOLX
392
DELISTED
Hologic
HOLX
| $31.1M | 0.06% |
900,946
+66,590
| +8% | +$2.32M |
|
|
EQC
393
DELISTED
Equity Commonwealth
EQC
| $31.1M | 0.06% |
1,101,158
+454,942
| +70% | +$12.3M |
|
|
INFO
394
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $31.1M | 0.06% |
878,765
+257,049
| +41% | +$7.47M |
|
|
CTRA
395
DELISTED
Coterra Energy
CTRA
| $31M | 0.06% |
1,364,584
+159,187
| +13% | +$3.19M |
|
396
American Airlines Group
AAL
$9.15B
| $31M | 0.06% |
755,624
+172,130
| +29% | +$6.93M |
|
397
Kirby Corp
KEX
$7.39B
| $30.4M | 0.05% |
505,040
-149,699
| -23% | -$8.16M |
|
398
Kohl's
KSS
$2B
| $30.3M | 0.05% |
+650,880
| New | +$30.5M |
|
399
Outfront Media
OUT
$5.25B
| $30.3M | 0.05% |
1,457,955
+235,471
| +19% | +$4.78M |
|
400
CALL
United Parcel Service
UPS
$86.8B
| $30.2M | 0.05% |
286,400
-351,000
| -55% | -$34.1M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.